A World View of Pharmaceutical innovation with Lesley Stolz and David Bearss
At this year’s Mayer Brown Utah Life Sciences Summit Dr. David Bearss, CEO of Halia Therapeutics interviews Leslie Stolz, VP Early Innovation Partnering, Johnson & Johnson about rigors of early stage pharmaceutical innovation. Both of these individuals are experienced experts in the field. […]